Category: Providers

Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals

October 5, 2023 Tom Mirga, Editor at Large Views

Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.

Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits

October 3, 2023 Tom Mirga, Editor at Large Views

Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.

Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Defend 340B Compliance Amid Influential Senator’s Investigation

October 3, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) expanded his ongoing inquiry into 340B revenue with letters to two major contract pharmacies.

The two hospital systems subject to a senator’s investigation into 340B program revenue have said they are fully compliant with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Key 340B Patient Definition Case, Hospital Group Accuses Drugmakers of “Numerous Misstatements”

October 3, 2023 Tom Mirga, Editor at Large Views

Chief Judge R. Bryan Harwell of the U.S. District Court for the District of South Carolina has not yet decided on 340B Health's request to file an amicus brief in a key 340B patient definition case.

A national hospital group has asked a federal district court for permission “to correct numerous misstatements” that it says drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

September 29, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.

The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

As Shutdown Looms, Momentum Slows on Bills with Key 340B Changes

September 28, 2023 William Newton, Associate Editor/Senior Writer Views

Rep. Harshbarger (R-Tenn.) co-sponsored a PBM transparency bill with a 340B provision, but there had not been any floor or committee votes scheduled on the legislation.

As the country moves closer to a federal government shutdown, movement on two bipartisan House bills with 340B program language, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

September 28, 2023 Tom Mirga, Editor at Large Views

Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.

Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health, Researchers Spar over Biosimilar Study

September 28, 2023 Rich Daly, Editor in Chief Views

Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.

Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Drug Purchases Reached $53.7 Billion in 2022, HRSA Data Show

September 26, 2023 Tom Mirga, Editor at Large Views

Drug purchases under the 340B program totaled $53.7 billion in 2022, according to HRSA data obtained by Drug Channels.

Drug purchases under the 340B program totaled $53.7 billion in 2022, or 22.3% more than the $43.9 billion in 2021, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital 340B Sites increased by 400% Over 11 Years, Analysis Finds

September 26, 2023 Rich Daly, Editor in Chief Views

A consulting firm analysis found that hospital 340B covered entity and child sites increased more than fourfold over the last 11 years.

Hospital 340B covered entity and child sites increased by more than 400% over the last 11 years, while the number [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live